
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts; 2 Department of Pathology, Universidad del Valle, Cali, Colombia; 3 Louisiana State University Health Sciences Center, New Orleans, Louisiana; and 4 Hospital San Andres, Tumaco, Colombia
Requests for reprints: Mark T. Whary, Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 16-825A, Cambridge, MA 02139. Phone: 617-253-9435; Fax: 617-258-5708. E-mail: mwhary{at}mit.edu
Background: Colombians living in coastal Tumaco have a lower incidence of Helicobacter pyloriassociated gastric cancer compared with residents of Pasto in the high Andes. Considering the risk for H. pylori disease seems affected by features of bacterial virulence and host polymorphisms, other poorly understood influences, such as concurrent helminthiasis, may also be important.
Methods: Fecal samples from 211 children were tested for parasites and sera from another cohort of 159 children and 92 adults were tested for IgE and H. pylorispecific IgG.
Results: Most individuals (95%) from both areas were H. pylori seropositive, with a predominant response of IgG1 followed by IgG2 and low IgG3 and IgG4 antibodies. Compared with Pasto children, Tumaco children were more commonly infected with helminths (P = 0.000), had higher serum IgE levels (P < 0.03), and had higher Th2-associated IgG1 responses to H. pylori (P < 0.0002). Other IgG isotype responses all increased with age but were not significantly different between children and adults from either area.
Conclusions: These results suggest that intestinal helminthiasis in children promotes Th2-polarizing responses to H. pylori and may decrease gastric cancer risk in these individuals later in life. Concurrent helminthiasis may alter inflammatory responses to H. pylori and thus affect the progression of gastritis to gastric atrophy, dysplasia, and cancer.
This article has been cited by other articles:
![]() |
A. Sayi, E. Kohler, I. Hitzler, I. Arnold, R. Schwendener, H. Rehrauer, and A. Muller The CD4+ T Cell-Mediated IFN-{gamma} Response to Helicobacter Infection Is Essential for Clearance and Determines Gastric Cancer Risk J. Immunol., June 1, 2009; 182(11): 7085 - 7101. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Lemke, Z. Ge, M. T. Whary, Y. Feng, A. B. Rogers, S. Muthupalani, and J. G. Fox Concurrent Helicobacter bilis Infection in C57BL/6 Mice Attenuates Proinflammatory H. pylori-Induced Gastric Pathology Infect. Immun., May 1, 2009; 77(5): 2147 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pisani, M. T. Whary, I. Nilsson, S. Sriamporn, T. Wadstrom, J. G. Fox, A. Ljungh, and D. Forman Cross-Reactivity between Immune Responses to Helicobacter bilis and Helicobacter pylori in a Population in Thailand at High Risk of Developing Cholangiocarcinoma Clin. Vaccine Immunol., September 1, 2008; 15(9): 1363 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G Fox Helicobacter-Associated Chronic Inflammation and Gastrointestinal Cancer Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 375 - 380. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |